Effects of treatment on respiratory rate, serum natriuretic peptide concentration, and Doppler echocardiographic indices of left ventricular filling pressure in dogs with congestive heart failure secondary to degenerative mitral valve disease and dilated cardiomyopathy

J Am Vet Med Assoc. 2011 Aug 15;239(4):468-79. doi: 10.2460/javma.239.4.468.

Abstract

Objective: To evaluate the effects of treatment on respiratory rate, serum natriuretic peptide concentrations, and Doppler echocardiographic indices of left ventricular filling pressure in dogs with congestive heart failure (CHF) secondary to degenerative mitral valve disease (MVD) and dilated cardiomyopathy (DCM).

Design: Prospective cohort study.

Animals: 63 client-owned dogs.

Procedures: Physical examination, thoracic radiography, analysis of natriuretic peptide concentrations, and Doppler echocardiography were performed twice, at baseline (examination 1) and 5 to 14 days later (examination 2). Home monitoring of respiratory rate was performed by the owners between examinations.

Results: In dogs with MVD, resolution of CHF was associated with a decrease in respiratory rate, serum N-terminal probrain natriuretic peptide (NT-proBNP) concentration, and diastolic functional class and an increase of the ratio of peak velocity of early diastolic transmitral flow to peak velocity of early diastolic lateral mitral annulus motion (E:Ea Lat). In dogs with DCM, resolution of CHF was associated with a decrease in respiratory rate and serum NT-proBNP concentration and significant changes in 7 Doppler echocardiographic variables, including a decrease of E:Ea Lat and the ratio of peak velocity of early diastolic transmitral flow to isovolumic relaxation time. Only respiratory rate predicted the presence of CHF at examination 2 with high accuracy.

Conclusions and clinical relevance: Resolution of CHF was associated with predictable changes in respiratory rate, serum NT-proBNP concentration, and selected Doppler echocardiographic variables in dogs with DCM and MVD. Home monitoring of respiratory rate was simple and was the most useful in the assessment of successful treatment of CHF.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiomyopathy, Dilated / complications
  • Cardiomyopathy, Dilated / veterinary*
  • Cardiovascular Agents / therapeutic use
  • Cohort Studies
  • Dog Diseases / drug therapy
  • Dogs
  • Echocardiography, Doppler / veterinary*
  • Heart Failure / drug therapy
  • Heart Failure / veterinary*
  • Mitral Valve Insufficiency / complications
  • Mitral Valve Insufficiency / veterinary*
  • Natriuretic Peptides / blood*
  • Respiration / drug effects*

Substances

  • Cardiovascular Agents
  • Natriuretic Peptides